Answers are grounded in this paper and cite their sources.
: Our data demonstrate that vitamin C kills thyroid cancer cells by inhibiting MAPK/ERK and PI3K/AKT pathways via a ROS-dependent mechanism and suggest that pharmaceutical concentration of vitamin C has potential clinical use in thyroid cancer therapy.
No takes yet. Share an insight, caveat, or question.
Su et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: